Axcan Helicide, Photofrin Barrett’s Approvals Expected By Year-End
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Axcan plans to position its Helicobacter pylori treatment Helicide as more effective than a clarithromycin-based regimen in antibiotic-resistant patients.